Actionnariat et activité des initiés pour Abivax S.A. (ABVX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $106.99 |
| Capitalisation | $7.9B |
| Bourse | NASDAQ |
| Pays | FR |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $7.9M | $1.9M | $8.0M | $9.8M | $29.3M | $60.7M | $26.9M | $251.9M | $144.2M | $516.5M |
| Placements à Court Terme | $15.1M | $15.2M | $5.0M | $6000 | $6000 | $6000 | 0 | $9.1M | 0 | $13.7M |
| Créances | $4.8M | $3.6M | $7.8M | $7.0M | $8.0M | $8.3M | $8.3M | $19.1M | $15.7M | $10.5M |
| Stocks | $52000 | $199000 | 0 | $1.2M | 0 | $4.0M | 0 | 0 | 0 | 0 |
| Actifs Courants | $27.8M | $20.9M | $21.0M | $18.2M | $37.7M | $75.2M | $36.2M | $286.0M | $170.7M | $551.0M |
| Immobilisations Corporelles | $192000 | $201000 | $151000 | $134000 | $100000 | $93000 | $1.6M | $877000 | $2.7M | $2.1M |
| Goodwill | $32.0M | $32.0M | $32.0M | $32.0M | $32.0M | $32.7M | $18.4M | $18.4M | $18.4M | $18.4M |
| Actifs Incorporels | 0 | 0 | 0 | $85000 | $98000 | -$647000 | $6.6M | $6.6M | $6.6M | $6.6M |
| Actifs Totaux | $60.6M | $53.8M | $54.0M | $51.7M | $71.3M | $109.2M | $75.5M | $327.1M | $205.2M | $584.1M |
| Dettes Fournisseurs | $2.6M | $4.2M | $6.7M | $10.5M | $17.4M | $18.6M | $15.5M | $47.2M | $43.8M | $37.6M |
| Dette à Court Terme | $255000 | 0 | $10.9M | $20.7M | $12000 | $10.1M | $29.5M | $30.9M | $42.8M | $28.5M |
| Passifs Courants | $3.5M | $5.4M | $8.5M | $12.4M | $19.4M | $32.3M | $51.5M | $88.1M | $92.8M | $63.0M |
| Dette à Long Terme | $316000 | 0 | $10.9M | $20.7M | $34.0M | $40.3M | $8.3M | $26.6M | $52.2M | $30.2M |
| Passifs Totaux | $3.9M | $5.6M | $19.4M | $33.1M | $53.4M | $83.3M | $68.4M | $131.1M | $164.6M | $129.1M |
| Réserves | -$35.4M | -$46.6M | -$62.4M | -$93.0M | -$37.6M | -$81.8M | -$143.5M | -$282.9M | -$438.9M | -$738.2M |
| Capitaux Propres | $56.7M | $48.2M | $34.7M | $18.6M | $17.9M | $25.9M | $7.2M | $196.0M | $40.6M | $455.0M |
| Dette Totale | $316000 | 0 | $10.9M | $20.7M | $34.0M | $51.7M | $39.2M | $58.0M | $97.4M | $45.9M |
| Dette Nette | -$22.7M | -$17.0M | -$2.1M | $11.0M | $4.7M | -$9.0M | $12.2M | -$202.9M | -$46.9M | -$484.3M |
| Fonds de Roulement | $24.3M | $15.4M | $12.5M | $5.9M | $18.3M | $42.9M | -$15.3M | $197.9M | $77.8M | $488.0M |
Santé financière
| Dette / Capitaux propres | 0.10 |
| Ratio de liquidité | 8.75 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 34.93 |
Rentabilité
| Rentabilité des capitaux propres | -73.87% |
| Rentabilité du capital investi | -44.70% |
| Rentabilité des actifs | -57.54% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: AXSM · CORT · CYTK · HALO · JAZZ · MDGL · MRUS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ABVX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions